Novo Nordisk’s $2 Billion License Agreement with United Laboratories

Leila Ahmed North America Legal Chronicle
Tagged:

Ropes & Gray advised Novo Nordisk on the transaction.Novo Nordisk announced an exclusive license agreement with China-based United Laboratories International Holdings Limited and its wholly-owned subsidiary…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here